HIND · Vyome Holdings, Inc

Track HIND — free

$1.86 +0.02 (+0.82%)

Rebalance outlook locked

Market Cap

$12.91M

7.02M

Volume · Oct 21 1371 Avg daily vol (3M) 12.87K

Up next

Latest filing: 10-Q

filed Aug 12, 2026

Q1 2026 earnings call transcript

call held Jun 3, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 122 metrics

Revenue (TTM)

$129,725

Trailing 12 months

Net income (TTM)

−$11.31M

Trailing 12 months

Revenue growth YoY

-46.0%

Year over year

Operating margin

-9,190.1%

Trailing 12 months

P / E (TTM)

0.0

Trailing earnings · reciprocal yield 84,585.9%

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+1,733,130.8%

Year over year · more shares

Price change (1Y)

-66.1%

Trailing year

Short interest

0.4%

Latest settlement · 1.0 days to cover

View all 122 metrics

Quarterly results

Revenue Net income Net loss

▼96.1% $84,526 −$547,772 '24 Q3 ▼288.5% −$3.74M $2.89M '24 Q4* ▼89.8% $198,581 −$293,974 '25 Q1 ▼97.5% $49,954 −$308,760 '25 Q2 ▼59% $34,627 −$8.43M '25 Q3 · $36,552 −$1.23M '25 Q4* ▼84.1% $31,591 −$962,910 '26 Q1 LATEST ▼46% $26,955 −$685,556 '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 17.3 · elevated Equity put/call 0.56

Technical

price trend

Strong Sell

50 / 200-day cross No cross

Price vs 200-day avg −20%

below

Price vs 50-day avg −11%

below

RSI (14) 36

neutral

MACD trend Negative

52-week position 0%

near low

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −6%

trailing

6-month return −10%

trailing

YTD return −47%

this year

Relative strength −18%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $2 › 200d $2 — 200d above 50d

Institutional flow Accumulating

+33% holders QoQ · +4 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

0.37% of float · ▲ +21.9% MoM · 1.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

12 holders — near 6-yr high, broad support

Squeeze score 36

low risk · 0–100

Fundamentals

Strong

Revenue growth +24%

Y/Y

Gross margin 68%

contracting

EPS growth +100%

Y/Y

Free cash flow $-3.9M

Balance sheet $9.8M

net debt

Quant / Vol

risk profile

Very High

Volatility 76%

annualized · 1-yr

Max drawdown −71%

past year

ATR 4.8%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell

4 · 3 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−20% Bearish

Price vs 50-day avg

−11% Bearish

RSI (14)

36 Neutral

MACD trend

Negative Bearish

52-week position

0% Bearish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $2 › 200d $2 — 200d above 50d

Institutional flow Accumulating

+33% holders QoQ · +4 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

0.37% of float · ▲ +21.9% MoM · 1.0 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

12 holders — near 6-yr high, broad support

Price context

position in its 52-week range

Range low $2 Now $2 · 0% Range high $6

vs 200-day avg -20% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
HIND Vyome Holdings, Inc this stock	$12.91M	-46.5%	+24.4%	—	0.4%
VRTX Vertex Pharmaceuticals Inc / Ma	$130.07B	+13.5%	+46.2%	29.9	1.8%
MRNA Moderna, Inc.	$96.65B	+720.9%	+4.3%	—	7.7%
REGN Regeneron Pharmaceuticals, Inc.	$83.13B	+4.6%	+20.8%	20.0	2.1%
CSLLY Csl Ltd	$66.34B	—	—	—	0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

% held: 2.0%
Net QoQ: +46.0K sh
Top holder: CITADEL ADVISORS LLC

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

26.2K

Days to cover: 1.0d
Change: +4.7K sh

View

Short Volume

Short vol %

42%

As of: Oct 20, 2026

Short Total

View

Fails to Deliver

FTD shares

5.9K

Value: $11.8K
As of: Sep 30, 2026

View

Off-Exchange

Off-exchange %

52.1%

Week of: Sep 14, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$319.7K

Net income (FY): $-10.3M
EPS diluted: $-4.86

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 28, 2026
This year: 11

View

Earnings & Events

Webcasts

Last webcast

Jun 3, 2026

View

Performance

	5D	20D	120D	MTD	YTD
HIND	-6.6%	-5.6%	-9.8%	-4.7%	-46.5%
SPY	-1.2%	-0.6%	+8.1%	+0.8%	+12.8%
vs SPY	-5.5%	-5.1%	-17.9%	-5.5%	-59.3%

Key facts CIK 1427570 CUSIP 92943X104 Visit website Investor relations

HIND · Vyome Holdings, Inc

Price & Indicators

Up next

Metrics snapshot

Quarterly results

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance